FDA.reportPublic FDA data

Fycompa 2 MG 2-Week Sample Kit

RxCUI
2641919
RxNorm name
Fycompa 2 MG 2-Week Sample Kit
Display name
Fycompa 2 MG 2-Week Sample Kit
Full name
Fycompa 2 MG 2-Week Sample Kit
Term type
SY
Status
DailyMed mapping
Updated
2026-06-04 23:39:26

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
FycompaPERAMPANELCatalyst Pharmaceuticals, Inc.ec812ea3-de3a-4271-957c-db8f692d1ae32024-01-05Boxed warning, Warnings, Adverse reactionsExact identifier
rxcui: 2641919

DailyMed RxNorm Mappings#

unique DailyMed labels mapped to this RxNorm concept page 1 of 1 · 1 matching rows.

Set ID, RxNorm mappings, Terms table
Set IDRxNorm mappingsTermsSPL versionLabelEffective
ec812ea3-de3a-4271-957c-db8f692d1ae3{14 (perampanel 2 MG Oral Tablet [FYCOMPA]) } Pack [Fycompa 2 MG 2-Week Sample Kit] [BPCK] · Fycompa 2 MG 2-Week Sample Kit [PSN] · Fycompa 2 MG 2-Week Sample Kit [SY]34These highlights do not include all the information needed to use FYCOMPA ® safely and effectively. See full prescribing information for FYCOMPA ® . FYCOMPA ® (perampanel) tablets, for oral use, CIII FYCOMPA ® (perampanel) oral suspension, CIII Initial U.S. Approval: 201220240105